SCHEMBL9529724

SCHEMBL9529724

CC1(C)C=C(N2CCCC2=O)c2cc(Cl)ccc2N1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 2/20 0.38
▸ PGR P06401 5/20 0.38
▸ AR P10275 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ G6PD P11413 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ TGM2 P21980 1/20 0.35
▸ CES1 P23141 1/20 0.35
▸ PDE7A Q13946 1/20 0.35
▸ NR3C1 P04150 1/20 0.35
▸ CHEK1 O14757 1/20 0.35
▸ HPGD P15428 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ AKR1B1 P15121 2/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9530317 0.85 MEN1 (0.40) LRRK2PGRARKDM4EMAPT
SCHEMBL9530870 0.82 PGR (0.41) LRRK2PGRARKDM4EMAPT
SCHEMBL9589108 0.78 LMNA (0.34) MAPTHSD17B10LMNAHPGDTSHR
SCHEMBL10758064 0.76 PSEN1 (0.37) MAPTHSD17B10LMNATP53HPGD
SCHEMBL9529728 0.76 CNR2 (0.42) MAPTLMNATGM2CES1PDE7A
SCHEMBL9530888 0.71 NPC1 (0.35) HSD17B10LMNACES1PDE7AHPGD
SCHEMBL10840367 0.69 KDM4E (0.47) PGRARKDM4EMAPTHSD17B10
SCHEMBL9532407 0.68 GRM5 (0.36) LMNAHPGDALDH1A1TSHR
SCHEMBL10840490 0.68 ALDH1A1 (0.69) PGRARKDM4EMAPTHSD17B10
SCHEMBL9846715 0.65 CTSD (0.36) KDM4EMAPTLMNATP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214743-B1 USE OF QUINOLINE DERIVATIVES IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF CEREBROVASCULAR DISORDERS AND CEREBRAL SENILITY BEECHAM GROUP PLC (GB) 1993-05-12 — — EP claimed
EP-0150202-B1 DI/TETRA-HYDROQUINOLINES BEECHAM GROUP PLC (GB) 1988-07-06 — — EP claimed
EP-0214743-A2 Use of quinoline derivatives in the manufacture of medicaments for the treatment of cerebrovascular disorders and cerebral senility BEECHAM GROUP PLC (GB) 1987-03-18 — — EP claimed
EP-0150202-A1 DI/TETRA-HYDROQUINOLINES. BEECHAM GROUP PLC (GB) 1985-08-07 — — EP claimed
WO-1985000602-A1 DI/TETRA-HYDROQUINOLINES BEECHAM GROUP P.L.C. (GB) 1985-02-14 — — WO claimed
EP-0214743-B1 USE OF QUINOLINE DERIVATIVES IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF CEREBROVASCULAR DISORDERS AND CEREBRAL SENILITY BEECHAM GROUP PLC (GB) 1993-05-12 — — EP disclosed
US-4808619-A HYPOTENSIVE AGENT, COGNITION ACTIVATOR BEECHAM GROUP P.L.C. (GB) 1989-02-28 — — US disclosed
US-4798619-A 2-(2-imidazolin-2-yl)-pyridines and quinolines and use of said compounds as herbicidal agents AMERICAN CYANAMID CO. (US) 1989-01-17 — — US disclosed
EP-0150202-B1 DI/TETRA-HYDROQUINOLINES BEECHAM GROUP PLC (GB) 1988-07-06 — — EP disclosed
EP-0214743-A2 Use of quinoline derivatives in the manufacture of medicaments for the treatment of cerebrovascular disorders and cerebral senility BEECHAM GROUP PLC (GB) 1987-03-18 — — EP disclosed
EP-0150202-A1 DI/TETRA-HYDROQUINOLINES. BEECHAM GROUP PLC (GB) 1985-08-07 — — EP disclosed
WO-1985000602-A1 DI/TETRA-HYDROQUINOLINES BEECHAM GROUP P.L.C. (GB) 1985-02-14 — — WO disclosed
Send feedback